Literature DB >> 18300355

Efficacies of beta-L-D4A against Hepatitis B virus in 2.2.15 cells.

Lin-Lin Gao1, Xiao-Yan Wang, Ju-Sheng Lin, Ying-Hui Zhang, Yan Li.   

Abstract

AIM: To investigate the antiviral effect of beta-L-enantiomer of 2',3'-didehydro-2',3'-dideoxyadenosine (beta-L-D4A) on 2.2.15 cells transfected with the hepatitis B virus (HBV) genome.
METHODS: Lamivudine (3TC) as a positive control. Then, HBV DNA in treated 2.2.15 cells and the Hepatitis B surface antigen (HBsAg) in the culture supernatants were detected to determine the inhibitory effect of beta-L-D4A. At the same time, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) was used to detect the survival ratio of 2.2.15 cells.
RESULTS: beta-L-D4A has a dose-dependent inhibitory effect on HBV DNA replication; this effect was apparent when the concentration was above 1 mol/L. When beta-L-D4A was at the highest concentration, 100 mol/L, the HBsAg inhibition ratio was above 50%. The Therapeutic index (TI) of beta-L-D4A was above 2.1.
CONCLUSION: beta-L-D4A has a dose-dependent inhibitory effect on the replication of HBV DNA and the secretion of HBsAg at low toxicity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18300355      PMCID: PMC2690677          DOI: 10.3748/wjg.14.1263

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  26 in total

1.  Cross-resistance testing of next-generation nucleoside and nucleotide analogues against lamivudine-resistant HBV.

Authors:  Huiling Yang; Xiaoping Qi; Alex Sabogal; Michael Miller; Shelly Xiong; William E Delaney
Journal:  Antivir Ther       Date:  2005

Review 2.  Hepatitis B virus infection.

Authors:  W M Lee
Journal:  N Engl J Med       Date:  1997-12-11       Impact factor: 91.245

Review 3.  The treatment of chronic viral hepatitis.

Authors:  J H Hoofnagle; A M di Bisceglie
Journal:  N Engl J Med       Date:  1997-01-30       Impact factor: 91.245

4.  Intracellular metabolism and in vitro activity of tenofovir against hepatitis B virus.

Authors:  William E Delaney; Adrian S Ray; Huiling Yang; Xiaoping Qi; Shelly Xiong; Yuao Zhu; Michael D Miller
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

5.  Expression of hepatitis B virus polymerase in Ty1-his3AI retroelement of Saccharomyces cerevisiae.

Authors:  I Qadri; A Siddiqui
Journal:  J Biol Chem       Date:  1999-10-29       Impact factor: 5.157

6.  Inhibition of hepatitis B virus polymerase by entecavir.

Authors:  David R Langley; Ann W Walsh; Carl J Baldick; Betsy J Eggers; Ronald E Rose; Steven M Levine; A Jayne Kapur; Richard J Colonno; Daniel J Tenney
Journal:  J Virol       Date:  2007-01-31       Impact factor: 5.103

7.  Generation of replication-competent hepatitis B virus nucleocapsids in insect cells.

Authors:  M Seifer; R Hamatake; M Bifano; D N Standring
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

8.  Design and synthesis of 2',3'-dideoxy-2',3'-didehydro-beta-L-cytidine (beta-L-d4C) and 2',3'-dideoxy 2',3'-didehydro-beta-L-5-fluorocytidine (beta-L-Fd4C), two exceptionally potent inhibitors of human hepatitis B virus (HBV) and potent inhibitors of human immunodeficiency virus (HIV) in vitro.

Authors:  T S Lin; M Z Luo; M C Liu; Y L Zhu; E Gullen; G E Dutschman; Y C Cheng
Journal:  J Med Chem       Date:  1996-04-26       Impact factor: 7.446

9.  In vitro susceptibility of adefovir-associated hepatitis B virus polymerase mutations to other antiviral agents.

Authors:  Xiaoping Qi; Shelly Xiong; Huiling Yang; Michael Miller; William E Delaney
Journal:  Antivir Ther       Date:  2007

10.  Nucleotide priming and reverse transcriptase activity of hepatitis B virus polymerase expressed in insect cells.

Authors:  R E Lanford; L Notvall; B Beames
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

View more
  1 in total

1.  Expression of hepatitis B virus 1.3-fold genome plasmid in an SV40 T-antigen-immortalized mouse hepatic cell line.

Authors:  Xiu-Guang Song; Peng-Fei Bian; Shu-Li Yu; Xiu-Hua Zhao; Wei Xu; Xue-Hui Bu; Xia Li; Li-Xian Ma
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.